Short answer
Beauty Health Co (SKIN) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $72M (down 7.8% year over year) with net income of −$3M.
Q2 2026 key financials · XBRL
- Revenue
- $72M
- −7.8% YoY · +11.1% QoQ
- Net income
- −$3M
- −113.5% YoY · +59.7% QoQ
- Operating margin
- 5.0%
- Gross margin
- 68.4%
- EPS (diluted)
- −$0.02
- −133.3% YoY · +60.0% QoQ
Source: XBRL data from the Beauty Health Co (SKIN) Q2 2026 10-Q on SEC EDGAR. USD.
Beauty Health Co Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $72.1M, down $6.1M or 7.8% YoY
- Gross margin 68.4% vs 62.8%; operating margin 5.0% vs negative 3.5% YoY
- Best segment Consumables $53.9M, down 3.5%; worst Delivery Systems $18.3M, down 18.4%
- Cash, cash equivalents, and restricted cash $206.1M as of June 30, 2026
- Headwinds: macroeconomic and credit conditions, tariffs, supply-chain constraints, older Syndeo issues, and treatment-volume pressure
Risk Factors
- New brand-reputation risk triggered by April 22, 2026 rebranding to SkinHealth Systems Inc
- Search-marketing risk from rebranding potentially reducing website rankings and increasing paid-traffic costs
- Nasdaq compliance risk after bid price below $1.00 for 30 consecutive business days
- Delisting mitigation depends on proposed 1-for-5 to 1-for-20 reverse stock split approval
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Beauty Health Co quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.